346 related articles for article (PubMed ID: 34950107)
41. A targeted analysis reveals relevant shifts in the methylation and transcription of genes responsible for bile acid homeostasis and drug metabolism in non-alcoholic fatty liver disease.
Schiöth HB; Boström A; Murphy SK; Erhart W; Hampe J; Moylan C; Mwinyi J
BMC Genomics; 2016 Jun; 17():462. PubMed ID: 27301979
[TBL] [Abstract][Full Text] [Related]
42. Transcriptomic evaluation of N6-methyladenosine modification can be used to identify differentially gene and immune-related biological processes in TX mice with liver fibrosis.
Zhang L; Huang X; Wang D; Fan C; Jiang H; Xie D
Mol Biol Rep; 2024 Jan; 51(1):149. PubMed ID: 38236359
[TBL] [Abstract][Full Text] [Related]
43. APOC3 Protein Is Not a Predisposing Factor for Fat-induced Nonalcoholic Fatty Liver Disease in Mice.
Cheng X; Yamauchi J; Lee S; Zhang T; Gong Z; Muzumdar R; Qu S; Dong HH
J Biol Chem; 2017 Mar; 292(9):3692-3705. PubMed ID: 28115523
[TBL] [Abstract][Full Text] [Related]
44. Comprehensive analysis of lncRNAs N
Zuo L; Su H; Zhang Q; Wu WY; Zeng Y; Li XM; Xiong J; Chen LF; Zhou Y
Aging (Albany NY); 2021 Jan; 13(3):4182-4198. PubMed ID: 33493136
[TBL] [Abstract][Full Text] [Related]
45. A retinoic acid receptor β2 agonist attenuates transcriptome and metabolome changes underlying nonalcohol-associated fatty liver disease.
Tang XH; Melis M; Lu C; Rappa A; Zhang T; Jessurun J; Gross SS; Gudas LJ
J Biol Chem; 2021 Dec; 297(6):101331. PubMed ID: 34688661
[TBL] [Abstract][Full Text] [Related]
46. Combined Methylation and Transcriptome Analysis of Liver Injury of Nonalcoholic Fatty Liver Disease Induced by High Alcohol-Producing Klebsiella pneumoniae.
Zhang R; Xu Z; Xue G; Feng J; Du B; Gan L; Fan Z; Fu T; Feng Y; Zhao H; Cui J; Yan C; Cui X; Tian Z; Chen J; Yu Z; Yuan J
Microbiol Spectr; 2023 Jun; 11(3):e0532322. PubMed ID: 37022192
[TBL] [Abstract][Full Text] [Related]
47. Genotoxic, epigenetic, and transcriptomic effects of tamoxifen in mouse liver.
de Conti A; Tryndyak V; Churchwell MI; Melnyk S; Latendresse JR; Muskhelishvili L; Beland FA; Pogribny IP
Toxicology; 2014 Nov; 325():12-20. PubMed ID: 25123088
[TBL] [Abstract][Full Text] [Related]
48. Epigenetic regulation of mRNA N6-methyladenosine modifications in mammalian gametogenesis.
Fang F; Wang X; Li Z; Ni K; Xiong C
Mol Hum Reprod; 2021 May; 27(5):. PubMed ID: 33823008
[TBL] [Abstract][Full Text] [Related]
49. Comparison of Gene Expression Patterns Between Mouse Models of Nonalcoholic Fatty Liver Disease and Liver Tissues From Patients.
Teufel A; Itzel T; Erhart W; Brosch M; Wang XY; Kim YO; von Schönfels W; Herrmann A; Brückner S; Stickel F; Dufour JF; Chavakis T; Hellerbrand C; Spang R; Maass T; Becker T; Schreiber S; Schafmayer C; Schuppan D; Hampe J
Gastroenterology; 2016 Sep; 151(3):513-525.e0. PubMed ID: 27318147
[TBL] [Abstract][Full Text] [Related]
50. Epitranscriptomic profiling of N6-methyladenosine-related RNA methylation in rat cerebral cortex following traumatic brain injury.
Yu J; Zhang Y; Ma H; Zeng R; Liu R; Wang P; Jin X; Zhao Y
Mol Brain; 2020 Jan; 13(1):11. PubMed ID: 31992337
[TBL] [Abstract][Full Text] [Related]
51. Metformin-Induced Changes of the Coding Transcriptome and Non-Coding RNAs in the Livers of Non-Alcoholic Fatty Liver Disease Mice.
Guo J; Zhou Y; Cheng Y; Fang W; Hu G; Wei J; Lin Y; Man Y; Guo L; Sun M; Cui Q; Li J
Cell Physiol Biochem; 2018; 45(4):1487-1505. PubMed ID: 29466788
[TBL] [Abstract][Full Text] [Related]
52. RNA N6-methyladenosine modification, spermatogenesis, and human male infertility.
Cai Z; Niu Y; Li H
Mol Hum Reprod; 2021 May; 27(6):. PubMed ID: 33749751
[TBL] [Abstract][Full Text] [Related]
53. Disruption of the mouse liver epitranscriptome by long-term aroclor 1260 exposure.
Piell KM; Petri BJ; Head KZ; Wahlang B; Xu R; Zhang X; Pan J; Rai SN; de Silva K; Chariker JH; Rouchka EC; Tan M; Li Y; Cave MC; Klinge CM
Environ Toxicol Pharmacol; 2023 Jun; 100():104138. PubMed ID: 37137421
[TBL] [Abstract][Full Text] [Related]
54. Relevance of N6-methyladenosine regulators for transcriptome: Implications for development and the cardiovascular system.
Sweaad WK; Stefanizzi FM; Chamorro-Jorganes A; Devaux Y; Emanueli C;
J Mol Cell Cardiol; 2021 Nov; 160():56-70. PubMed ID: 33991529
[TBL] [Abstract][Full Text] [Related]
55. KIAA1429 contributes to liver cancer progression through N6-methyladenosine-dependent post-transcriptional modification of GATA3.
Lan T; Li H; Zhang D; Xu L; Liu H; Hao X; Yan X; Liao H; Chen X; Xie K; Li J; Liao M; Huang J; Yuan K; Zeng Y; Wu H
Mol Cancer; 2019 Dec; 18(1):186. PubMed ID: 31856849
[TBL] [Abstract][Full Text] [Related]
56. N6-methyladenosine RNA methylation in liver diseases: from mechanism to treatment.
Yang L; Tian S; Zheng X; Zhang M; Zhou X; Shang Y; Han Y
J Gastroenterol; 2023 Aug; 58(8):718-733. PubMed ID: 37380929
[TBL] [Abstract][Full Text] [Related]
57. N6-methyladenosine-methylomic landscape of lung tissues of mice with chronic obstructive pulmonary disease.
Hu T; Xu L; Jiang M; Zhang F; Li Q; Li Z; Wu C; Ding J; Li F; Wang J
Front Immunol; 2023; 14():1137195. PubMed ID: 37056763
[TBL] [Abstract][Full Text] [Related]
58. Target genes associated with lipid and glucose metabolism in non-alcoholic fatty liver disease.
Li T; Yan H; Geng Y; Shi H; Li H; Wang S; Wang Y; Xu J; Zhao G; Lu X
Lipids Health Dis; 2019 Dec; 18(1):211. PubMed ID: 31805951
[TBL] [Abstract][Full Text] [Related]
59. Profiling of RNA N6-methyladenosine methylation during follicle selection in chicken ovary.
Fan Y; Zhang C; Zhu G
Poult Sci; 2019 Nov; 98(11):6117-6124. PubMed ID: 31189182
[TBL] [Abstract][Full Text] [Related]
60. The N
Dorn LE; Lasman L; Chen J; Xu X; Hund TJ; Medvedovic M; Hanna JH; van Berlo JH; Accornero F
Circulation; 2019 Jan; 139(4):533-545. PubMed ID: 30586742
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
